Corning, SGD Pharma Open Glass Tubing Plant in Telangana

Corning, SGD Pharma Open Glass Tubing Plant in Telangana

Industry Outlook Team | Monday, 22 September 2025

The opening of a new glass tubing factory in Telangana by Corning Incorporated and SGD Pharma would increase pharmaceutical production in the area. The new facility will help address capacity issues and quality requirements in primary glass packaging by combining SGD Pharma's vial-converting expertise with Corning's cutting-edge Velocity Vial technology.High-grade Type I borosilicate glass tubing, an essential component of injectable medication packaging, direct injection delivery systems, diagnostics, and biologics, will be produced at the new facility.

Corning's exclusive Velocity Vial glass-coating technology and SGD Pharma's experience in vial conversion will be used to improve vial quality, increase filling-line efficiency, and speed up the delivery of injectable therapies.

The plant will also provide sustainability and product quality efficiencies by co-locating tubing production and vial conversion. “The inauguration of this facility marks an important milestone in addressing critical regional needs, such as expanded production capacity, proximity to customers, and the localization of supply chains,” said Chris Hudson, vice president and general manager, Corning Life Sciences.

Also Read: Supriya Lifescience Expands Production to Strengthen Market Position

“This facility will play a vital role in India in accelerating the delivery of injectable treatments, supporting local pharmaceutical growth, and ensuring safer, more efficient access to critical medicines.”

“This joint venture with Corning marks a major milestone in our global growth strategy. By establishing a state-of-the-art glass tubing facility in Telangana, we are not only securing a critical part of our supply chain but also bringing world-class technology to one of the fastest-growing pharmaceutical markets,” said Olivier Rousseau, CEO, SGD Pharma.

on the deck

Most Viewed

Related Articles


© 2025 India Pharma Outlook. All Rights Reserved.